ARTICLE
15 April 2021

Liberalisation Of Regulations On The Use Of Cannabis-Based Medical Products In Ukraine

K
Kinstellar

Contributor

Kinstellar acts as trusted legal counsel to leading investors across Emerging Europe and Central Asia. With offices in 11 jurisdictions and over 350 local and international lawyers, we deliver consistent, joined-up legal advice and assistance across diverse regional markets – together with the know-how and experience to champion your interests while minimising exposure to risk.
Ukraine has taken a step towards liberalising regulations on the use of cannabis-based medicines. In particular, the Cabinet of Ministers has legalized...
Ukraine Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

April 2021 – Ukraine has taken a step towards liberalising regulations on the use of cannabis-based medicines. In particular, the Cabinet of Ministers has legalized:

  • Nabilone (a synthetic cannabinoid, mimicking the effect of THC); and
  • Nabiximols (a specific cannabis extract with the same content of THC and cannabidiol).

The psychotropic substances Dronabinol, Nabilon and Nabiximols are allowed only in the form of medicines (on prescription) or in the form of substances intended for the production and manufacture of such medicines.

To recap, medical use of cannabis is currently prohibited in Ukraine. Subject to obtaining of a relevant license, cannabis is permitted for (i) forensic examination; (ii) operational investigations in connection with criminal intelligence and surveillance operations; (iii) academic research and educational purposes (if such purpose is sanctioned by law); and (iv) for the cultivation and use of low THC-yielding plants (0.08%), only for industrial purposes and not for medical treatment.

Importantly, in 2020, according to results of a nationwide opinion poll, Ukrainians voiced their support for the legalisation of medical cannabis. In addition, four alternative draft laws on the legalisation of medical cannabis were registered in the Ukrainian parliament over the past 6 months.

We will keep you posted with any updates.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
15 April 2021

Liberalisation Of Regulations On The Use Of Cannabis-Based Medical Products In Ukraine

Ukraine Cannabis & Hemp

Contributor

Kinstellar acts as trusted legal counsel to leading investors across Emerging Europe and Central Asia. With offices in 11 jurisdictions and over 350 local and international lawyers, we deliver consistent, joined-up legal advice and assistance across diverse regional markets – together with the know-how and experience to champion your interests while minimising exposure to risk.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More